Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 24, 2022
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
[ Fri, Jun 24th 2022
] - WOPRAI
Thu, June 23, 2022
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
[ Thu, Jun 23rd 2022
] - WOPRAI
Andrew Tsai Downgraded (ATHA) to Hold and Decreased Target to $3 on, Jun 23rd, 2022
Andrew Tsai of Jefferies, Downgraded "Athira Pharma, Inc." (ATHA) to Hold and Decreased Target from $32 to $3 on, Jun 23rd, 2022.
Andrew has made no other calls on ATHA in the last 4 months.
There are 2 other peers that have a rating on ATHA. Out of the 2 peers that are also analyzing ATHA, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Thomas Shrader of "BTIG" Initiated at Strong Buy and Held Target at $33 on, Tuesday, May 10th, 2022
- Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022
